Two-Year Ban On US Device Tax Clinched In Tax-Extenders Bill, Passage Expected Soon
This article was originally published in SRA
Executive Summary
US House and Senate negotiators reached a compromise agreement early Dec. 16 to place a two-year delay on the medical device tax as part of a tax-extenders bill, a move hailed by the device and medical imaging industry1. However, the House and Senate still have to vote on the bill, the Protecting Americans from Tax Hikes Act of 2015, which also includes a permanent extension of the research and development tax credit2.
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.